Skip to content
AP
Company

Updated:

ACCELERON PHARMA INC

ACCELERON PHARMA INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001280600, and its reported industry is...

Overview

ACCELERON PHARMA INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001280600, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2021-02-25, it reported annual revenue of USD 92,523,000; net income of USD -166,030,000; total assets of USD 932,337,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
ACCELERON PHARMA INC
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001280600

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2020USD$92.5M-$166.0M$932.3M$671.0M-$130.3M
FY2019USD$74.0M-$124.9M$504.9M$237.7M-$93.8M
FY2018USD$14.0M-$118.9M$314.8M$144.1M-$94.7M
FY2017USD$13.5M-$108.5M$389.2M$100.2M-$76.7M

FY2017. Operating cash flow: shown as originally filed; later filings report different values for the same periods.

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
10-Q10-Q
8-K8-K
8-K8-K
SC 13D—ACCELERON PHARMA INC.
8-KFORM 8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research ACCELERON PHARMA INC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

ACCELERON PHARMA INC | Cambridge Company | Altss